Novus Acquisition & Development Corp. Makes Key Executive Appointment
MIAMI, FL -- (Marketwired) -- 06/10/14 -- Novus Acquisition &
Development Corp (OTC Pink: NDEV) (PINKSHEETS: NDEV) has appointed
Andrea Lopez, MSM, AHFI as an Executive Board Member and the new CEO
for its Medical Marijuana "MMJ" subsidiary Novus Medical Group, Inc.
d/b/a Novus MedPlan, in which she will lead the company into
healthcare medical plan and health insurance related services.
Ms. Lopez's fifteen year tenure of global operational experience has
included many facets of compliance and roll out of the healthcare
delivery processes. Specifically, creating and maintaining health
care policies under the performance standards and scrutiny of
Medicare, and Fortune 500 Companies. She is an active member of the
Global Healthcare Anti-Fraud Network, the National Health Care
Anti-Fraud Association, the European Healthcare Fraud & Corruption
Network, and the Health Care Compliance Association.
As a member of the Board of Directors and CEO of Novus Medical Group,
Inc. d/b/a Novus MedPlan, Ms. Lopez will develop a medical plan
putting Novus on the path of a Health Care Insurance program called
the "MedPlan Program". The MedPlan Program will seek to deliver a
health insurance format to patients interested in using medical
marijuana in the states where it is legal.
Frank Labrozzi, Novus' CEO states, "After reviewing Ms Lopez's
credentials, especially her tenure at International SOS, Express
Scripts and PCS (now owned by Caremark), where she developed and led
enterprise-wide efforts at the executive level, rolled out global
Health Care programs with tight internal controls, and detailed
policies and procedures to mitigate risk, we knew her experience
would prove invaluable to our team."
Andrea received both a Master of Science in Security Management (MSM)
and a Bachelor of Science degree in Criminal Justice Administration
from the prestigious Bellevue University. We welcome her to the Novus
Novus is comprised of seasoned Wall Street veterans
that have focused its business model in the healthcare portion of the
medical cannabis industry. Management and its proposed future Board
of Directors areas of expertise will diversify in Healthcare,
Physicians Education, Pharma R&D, Compliance and Business
Development. NDEV will work as an outside developer's and since MMJ
is not Federally approved it will not cultivate, handle, transport
grow, extract, dispense put up for sale, put on the market, vend,
deliver, supply, circulate, trade, cannabis or any substances that
violates the United States law or the Controlled Substances Act, nor
does it intend to do so in the future and will continue to follow
state and federal laws.
For Investor Relations contact:
Main Tel: (855) 422-4463
Gary F. Labrozzi
Website: www.ndev.biz or www.novusqc.com
Press spacebar to pause and continue. Press esc to stop.